10x Genomics, Inc.
TXG
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
10x Genomics, Inc., společnost zabývající se biotechnologiemi, vyvíjí a prodává nástroje, spotřební materiál a software pro analýzu biologických systémů v Severní Americe, Evropě, na Blízkém východě, v Africe, Číně a v Asii a Pacifiku. Společnost dodává chromové a chromové spojovací přístroje, mikrofluidní čipy, preparáty, činidla a další spotřební materiály. Jeho jednobuněčné roztoky probíhají na chromových přístrojích, které zahrnují expresi genů pro jednotlivé buňky pro měření aktivity genů; imunologické profilování jednotlivých buněk pro měření aktivity imunitních buněk a jejich cílů; test jednobuněčných buněk pro transpoázovou přístupnou chromatiku (ATAC) pro měření epigenetiky zahrnující fyzickou organizaci DNA; a expresi genů jednobuněčného multiomu ATAC + pro měření genetické aktivity a epigenetického programování ve stejných buňkách napříč desítkami tisíc buněk v jediném experimentu. Společnost také poskytuje řešení prostorové exprese genů pro měření vzorců prostorové exprese genů napříč jediným vzorkem tkáně nebo genovou expresi a kodetekci proteinů v kombinaci s imunofluorescencí. Slouží různým akademickým, vládním, biofarmaceutickým, biotechnologickým a dalším institucím. Společnost byla dříve známá jako 10X Technologies, Inc. a v listopadu 2014 změnila svůj název na 10x Genomics, Inc. 10x Genomics, Inc. byla založena v roce 2012 a sídlí v Pleasantonu v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Healthcare Information Services
Počet zaměstnanců
1306
Založení
2019-09-12
Podobné společnosti
$ 18.29
+ $ 0.51
$ 23.83
+ $ 1.46
$ 7.55
+ $ 0.02
$ 27.09
+ $ 0.61
$ 36.26
+ $ 0.58
$ 4.64
- $ 0.09
$ 8.85
+ $ 0.18
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 642.8 | 642.8 | 610.8 | 618.7 | 516.4 | 490.5 | 298.8 | 245.9 | 146.3 | 71.1 | |
| Cost of Revenues | 198.9 | 198.9 | 196.3 | 209.4 | 120.4 | 74.1 | 58.5 | 61.0 | 28.7 | 10.6 | |
| Gross Profit | 443.9 | 443.9 | 414.5 | 409.3 | 396.0 | 416.4 | 240.4 | 184.9 | 117.7 | 60.5 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 166.0 | 149.0 | 172.9 | 154.9 | 165.0 | 151.7 | 153.1 | 141.0 | 184.0 | 153.6 | |
| Cost of Revenues | 53.0 | 48.7 | 47.8 | 49.4 | 54.1 | 45.3 | 48.9 | 48.1 | 77.9 | 58.1 | |
| Gross Profit | 113.0 | 100.3 | 125.1 | 105.4 | 111.0 | 106.4 | 104.2 | 92.9 | 106.1 | 95.5 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 270.3 | 265.7 | 211.8 | 123.4 | 83.1 | 47.5 | 32.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 343.3 | 298.3 | 257.6 | 202.3 | 130.8 | 87.9 | 46.7 | |
| Depreciation & Amortization | 31.7 | 0.0 | 43.7 | 43.6 | 6.4 | -0.6 | 2.9 | 2.6 | 3.9 | 4.3 | |
| Total Operating Expenses | 504.9 | 554.8 | 609.0 | 674.9 | 564.0 | 469.3 | 325.7 | 213.9 | 135.5 | 78.9 | |
| Operating Income | -61.0 | -110.9 | -194.6 | -265.3 | -167.9 | -52.9 | -85.3 | -29.1 | -110.8 | -18.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 55.6 | 107.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 86.1 | 82.4 | ||
| Depreciation & Amortization | 0.0 | 12.3 | 9.7 | 9.8 | 10.6 | 10.8 | 10.9 | 11.5 | 11.7 | 11.4 | ||
| Total Operating Expenses | 132.6 | 132.5 | 95.0 | 144.8 | 160.8 | 147.9 | 146.0 | 154.4 | 141.7 | 190.3 | ||
| Operating Income | -19.5 | -32.2 | 30.1 | -39.3 | -49.8 | -41.5 | -41.7 | -61.5 | -35.6 | -94.8 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 18.6 | 20.0 | 18.4 | 16.9 | 6.6 | 0.2 | 1.5 | 2.8 | 1.0 | 0.3 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.9 | 1.7 | 3.1 | 2.4 | 0.8 | |
| Other Expense | 21.1 | 71.0 | 16.9 | 16.6 | 6.0 | -0.8 | -449.2 | -2.0 | -93.2 | 0.1 | |
| IBT | -39.9 | -39.9 | -177.7 | -248.8 | -162.0 | -53.7 | -534.5 | -31.0 | -112.4 | -18.7 | |
| Income Tax Expense | 3.6 | 3.6 | 4.9 | 6.3 | 4.0 | 4.5 | 8.3 | 0.2 | 0.1 | 0.0 | |
| Net Income | -43.5 | -43.5 | -182.6 | -255.1 | -166.0 | -58.2 | -542.7 | -31.3 | -112.5 | -18.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 5.5 | 5.2 | 4.3 | 3.7 | 4.0 | 5.0 | 4.7 | 4.7 | 4.6 | 4.3 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | 4.3 | 4.0 | 6.9 | 5.8 | 1.5 | 7.0 | 4.7 | 3.7 | -11.0 | 3.1 | ||
| IBT | -15.2 | -28.2 | 37.0 | -33.5 | -48.4 | -34.4 | -37.1 | -57.8 | -46.6 | -91.7 | ||
| Income Tax Expense | 1.1 | -0.7 | 2.5 | 0.9 | 0.6 | 1.3 | 0.8 | 2.1 | 2.4 | 1.2 | ||
| Net Income | -16.3 | -27.5 | 34.5 | -34.4 | -49.0 | -35.8 | -37.9 | -59.9 | -49.0 | -93.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | $-1.36 | $-0.24 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | $-1.36 | $-0.24 | |
| Shares Outstanding | 127.1 | 124.7 | 120.5 | 117.2 | 113.9 | 110.3 | 101.2 | 39.1 | 82.9 | 77.5 | |
| Diluted Shares Outstanding | 127.1 | 124.7 | 120.5 | 117.2 | 113.9 | 110.3 | 101.2 | 39.1 | 82.9 | 77.5 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.41 | $-0.79 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.41 | $-0.79 | ||
| Shares Outstanding | 127.1 | 125.5 | 123.8 | 122.6 | 121.6 | 120.7 | 120.1 | 119.4 | 118.6 | 117.7 | ||
| Diluted Shares Outstanding | 127.1 | 125.5 | 124.5 | 122.6 | 121.6 | 120.7 | 120.1 | 119.4 | 118.6 | 117.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 379.8 | 344.1 | 359.3 | 219.7 | 587.4 | 663.6 | 424.2 | 65.1 | 47.9 | |
| Short Term Investments | 0.3 | 49.3 | 29.4 | 210.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 380.1 | 393.4 | 388.7 | 430.0 | 587.4 | 663.6 | 424.2 | 65.1 | 47.9 | |
| Accounts Receivable | 91.2 | 87.9 | 114.8 | 104.2 | 85.3 | 51.2 | 33.4 | 29.6 | 13.3 | |
| Inventory | 88.3 | 83.1 | 73.7 | 81.6 | 60.0 | 30.0 | 15.3 | 8.6 | 4.8 | |
| Other Current Assets | 19.6 | 20.0 | 18.8 | 16.6 | 14.9 | 29.6 | 8.0 | 3.0 | 2.1 | |
| Total Current Assets | 579.2 | 584.4 | 596.0 | 635.0 | 747.6 | 774.4 | 480.8 | 106.2 | 68.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 432.5 | 397.7 | 377.1 | 344.1 | 398.2 | 379.8 | 355.8 | 359.3 | 311.3 | 325.9 | |
| Short Term Investments | 49.6 | 49.5 | 49.8 | 49.3 | 0.0 | 0.3 | 16.0 | 29.4 | 45.6 | 65.5 | |
| Total Cash & ST Investments | 482.1 | 447.3 | 426.9 | 393.4 | 398.2 | 380.1 | 371.8 | 388.7 | 356.9 | 391.4 | |
| Accounts Receivable | 96.6 | 119.1 | 52.5 | 87.9 | 83.5 | 91.2 | 91.3 | 114.8 | 103.8 | 87.7 | |
| Inventory | 62.0 | 69.0 | 74.7 | 83.1 | 94.1 | 88.3 | 83.2 | 73.7 | 80.9 | 83.7 | |
| Other Current Assets | 19.2 | 20.4 | 25.6 | 20.0 | 18.2 | 19.6 | 20.8 | 18.8 | 20.7 | 20.2 | |
| Total Current Assets | 659.8 | 655.7 | 579.7 | 584.4 | 593.9 | 579.2 | 567.1 | 596.0 | 562.3 | 582.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 324.2 | 309.9 | 344.9 | 359.2 | 230.4 | 119.8 | 48.8 | 11.1 | 6.9 | |
| Goodwill | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 16.7 | 15.7 | 16.6 | 22.9 | 25.4 | 22.4 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 5.2 | 4.1 | 3.1 | 7.4 | 10.9 | 12.8 | 76.3 | 6.9 | 0.6 | |
| Total Long-Term Assets | 350.5 | 334.2 | 369.1 | 393.9 | 271.2 | 155.0 | 125.1 | 18.1 | 7.5 | |
| Total Assets | 929.7 | 918.6 | 965.1 | 1,029.0 | 1,018.8 | 929.3 | 605.9 | 124.3 | 75.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 296.2 | 302.4 | 301.7 | 309.9 | 318.3 | 324.2 | 332.3 | 344.9 | 354.2 | 356.0 | |
| Goodwill | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | |
| Intangible Assets | 64.8 | 14.7 | 15.2 | 15.7 | 16.1 | 16.7 | 16.1 | 16.6 | 21.8 | 22.3 | |
| Long-Term Investments | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.0 | 3.5 | |
| Other Long-Term Assets | 1.9 | 2.7 | 2.3 | 4.1 | 4.9 | 5.2 | 2.8 | 3.1 | 5.6 | 23.9 | |
| Total Long-Term Assets | 367.5 | 324.3 | 323.7 | 334.2 | 343.9 | 350.5 | 355.8 | 369.1 | 386.2 | 406.7 | |
| Total Assets | 1,027.4 | 980.0 | 903.4 | 918.6 | 937.8 | 929.7 | 922.9 | 965.1 | 948.5 | 989.6 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 21.2 | 12.9 | 15.7 | 21.6 | 17.4 | 4.7 | 13.0 | 8.8 | 5.4 | |
| Short-Term Debt | 10.8 | 9.3 | 23.0 | 9.0 | 5.1 | 5.9 | 9.9 | 4.2 | 4.2 | |
| Other Current Liabilities | 62.5 | 69.8 | 70.2 | 92.5 | 82.5 | 103.0 | 36.8 | 16.6 | 10.6 | |
| Current Liabilities | 111.0 | 117.6 | 127.2 | 131.0 | 110.4 | 118.1 | 63.0 | 32.4 | 22.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.1 | 15.9 | 10.1 | 12.9 | 26.2 | 21.2 | 20.2 | 15.7 | 18.8 | 23.1 | |
| Short-Term Debt | 10.5 | 9.7 | 9.4 | 9.3 | 9.4 | 10.8 | 11.1 | 23.0 | 20.0 | 18.6 | |
| Other Current Liabilities | 96.6 | 65.2 | 62.7 | 69.8 | 63.6 | 56.7 | 57.3 | 70.2 | 51.0 | 44.9 | |
| Current Liabilities | 147.3 | 112.2 | 107.9 | 117.6 | 121.2 | 111.0 | 108.7 | 127.2 | 104.7 | 98.1 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 78.7 | 73.3 | 167.7 | 86.1 | 76.8 | 57.0 | 19.8 | 25.5 | 6.3 | |
| Capital Leases | 78.7 | 82.6 | 95.4 | 95.2 | 82.0 | 63.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | -83.8 | 0.0 | 0.0 | 0.0 | 101.0 | 284.6 | 158.4 | |
| Total Liabilities | 205.6 | 208.5 | 224.1 | 223.2 | 201.3 | 190.3 | 185.8 | 344.3 | 188.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 76.4 | 77.1 | 70.6 | 73.3 | 76.5 | 78.7 | 81.0 | 167.7 | 176.9 | 180.7 | |
| Capital Leases | 0.0 | 86.7 | 80.1 | 82.6 | 85.9 | 78.7 | 92.2 | 83.8 | 98.5 | 99.6 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 241.0 | 206.7 | 196.5 | 208.5 | 215.0 | 205.6 | 204.1 | 224.1 | 203.3 | 196.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,382.3 | -1,467.0 | -1,284.4 | -1,029.3 | -863.3 | -805.1 | -262.4 | -231.1 | -118.6 | |
| Comprehensive Income | -0.4 | -0.5 | -0.4 | -4.3 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 724.1 | 710.1 | 741.0 | 805.7 | 817.6 | 739.1 | 420.1 | -220.0 | -112.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,494.3 | -1,466.9 | -1,501.4 | -1,467.0 | -1,418.0 | -1,382.3 | -1,344.4 | -1,284.4 | -1,235.5 | -1,142.5 | |
| Comprehensive Income | 0.1 | 0.2 | -0.4 | -0.5 | 0.0 | -0.4 | -0.5 | -0.4 | -0.7 | -1.0 | |
| Total Common Equity | 785.1 | 773.3 | 706.9 | 710.1 | 722.8 | 724.1 | 718.8 | 741.0 | 745.2 | 793.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 89.5 | 82.6 | 95.4 | 95.2 | 82.0 | 63.0 | 29.7 | 29.7 | 10.6 | |
| Book Value | 724.1 | 710.1 | 741.0 | 805.7 | 817.6 | 739.1 | 420.1 | -220.0 | -112.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 785.1 | 773.3 | 706.9 | 710.1 | 722.8 | 724.1 | 718.8 | 741.0 | 745.2 | 793.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -239.8 | -43.5 | -182.6 | -255.1 | -166.0 | -58.2 | -542.7 | -31.3 | -112.5 | -18.8 | |
| Depreciation & Amortization | 45.5 | 43.8 | 43.7 | 43.6 | 33.0 | 28.3 | 19.0 | 7.1 | 3.9 | 4.3 | |
| Stock-Based Compensation | 153.8 | 109.1 | 140.7 | 167.0 | 136.8 | 96.0 | 48.6 | 13.3 | 2.7 | 1.7 | |
| Change Working Capital | 22.9 | 24.9 | 1.3 | 17.3 | -39.4 | -87.4 | -50.4 | 44.8 | 28.0 | 1.9 | |
| Change In Accounts Receivable | -3.5 | 6.4 | 27.0 | -10.6 | -18.9 | -34.0 | -17.8 | -5.3 | -14.7 | -5.1 | |
| Change In Accounts Payable | -1.6 | -2.1 | -3.4 | -6.0 | 5.9 | 11.1 | -7.8 | 4.9 | 2.6 | 3.0 | |
| Change In Inventories | -5.0 | 28.0 | -9.8 | 7.9 | -21.2 | -30.1 | -14.6 | -6.7 | -3.7 | -2.0 | |
| Other Non-cash Items | 117.8 | 1.7 | 3.6 | 12.0 | 2.0 | 0.1 | 306.0 | 0.1 | 1.2 | 0.1 | |
| Cash from Operations | -7.8 | 0.0 | 0.0 | -15.2 | -33.6 | -21.4 | -217.9 | 34.6 | -76.4 | -10.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -16.3 | -27.5 | 34.5 | -34.4 | -49.0 | -35.8 | -37.9 | -59.9 | -49.0 | -93.0 | |
| Depreciation & Amortization | 12.1 | 12.3 | 9.7 | 9.8 | 10.6 | 10.8 | 10.9 | 11.5 | 11.7 | 11.4 | |
| Stock-Based Compensation | 25.2 | 25.3 | 27.6 | 31.1 | 32.5 | 33.6 | 38.5 | 36.1 | 38.9 | 40.2 | |
| Change Working Capital | 18.6 | 31.8 | -53.7 | 28.3 | -1.4 | 13.0 | -4.1 | -6.3 | 17.1 | 16.2 | |
| Change In Accounts Receivable | 14.1 | 22.9 | -65.9 | 35.3 | -4.4 | 7.7 | 0.1 | 23.5 | -11.0 | -16.2 | |
| Change In Accounts Payable | -5.4 | -0.2 | 6.0 | -2.5 | -13.4 | 4.3 | 1.1 | 4.6 | -3.2 | -4.1 | |
| Change In Inventories | 5.6 | 7.3 | 7.0 | 8.1 | 9.6 | -4.3 | -5.2 | -9.9 | 7.6 | 2.6 | |
| Other Non-cash Items | 1.1 | 1.4 | -0.4 | -0.5 | 0.6 | 0.1 | 0.1 | 2.9 | -16.8 | 26.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.8 | -25.3 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -25.7 | -5.9 | -12.4 | -48.6 | -131.7 | -101.3 | -38.4 | -42.8 | -6.7 | -3.8 | |
| Acquisitions | 0.0 | -9.3 | 0.0 | 0.0 | -4.0 | -5.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | -123.4 | -48.9 | 0.0 | -282.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 66.3 | 125.2 | 29.6 | 183.0 | 67.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 33.7 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 40.6 | 0.0 | 0.0 | 133.5 | -350.9 | -106.7 | -38.4 | -42.8 | -6.7 | -3.8 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.8 | -0.7 | -1.6 | -1.9 | -2.7 | -3.9 | -3.9 | -2.9 | -3.5 | -15.4 | |
| Acquisitions | 0.0 | -8.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -24.6 | -49.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 25.2 | 50.0 | 50.0 | 0.0 | 0.0 | 0.3 | 15.8 | 13.5 | 16.5 | 20.3 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.1 | 4.9 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -31.3 | -11.0 | -0.8 | -0.4 | |
| Debt Issued | -10.1 | 82.6 | -12.8 | 0.2 | 13.2 | 19.0 | 64.5 | 11.0 | 19.9 | 11.0 | |
| Issuance of Common Stock | 16.2 | 0.0 | 0.0 | 19.5 | 21.2 | 0.0 | 482.3 | 410.8 | 1.8 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 14.0 | 0.0 | 0.0 | 13.7 | -5.4 | 35.3 | 17.9 | 14.8 | 104.3 | 21.1 | |
| Cash from Financing | 16.2 | 0.0 | 0.0 | 13.7 | 15.8 | 35.3 | 468.9 | 414.6 | 105.4 | 20.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 87.0 | 0.2 | 6.7 | -2.5 | -3.3 | -3.6 | -2.7 | -3.2 | -3.1 | -1.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.6 | 4.4 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.6 | 4.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.6 | 4.4 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 52.4 | 129.9 | -15.2 | 131.9 | -368.7 | -92.6 | 212.2 | 406.4 | 22.2 | 6.1 | |
| Closing Cash Balance | 379.8 | 474.0 | 344.1 | 359.3 | 227.4 | 596.1 | 688.6 | 476.5 | 70.1 | 47.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 41.3 | 35.0 | 20.7 | 33.0 | -54.1 | 18.3 | 24.0 | -3.5 | 47.5 | -15.6 | |
| Closing Cash Balance | 474.0 | 432.7 | 397.7 | 377.1 | 344.1 | 398.2 | 379.8 | 355.8 | 359.3 | 311.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -33.4 | 130.1 | -5.7 | -64.7 | -165.3 | -122.7 | -256.3 | -8.1 | -83.1 | -14.5 | |
| Real Free Cash Flow | -187.2 | 21.0 | -146.5 | -231.7 | -302.1 | -218.6 | -304.9 | -21.5 | -85.8 | -16.1 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 39.0 | 42.5 | 16.1 | 32.5 | -9.5 | 17.8 | 3.6 | -18.6 | 22.3 | -40.7 | |
| Real Free Cash Flow | 13.8 | 17.3 | -11.4 | 1.4 | -42.0 | -15.8 | -34.9 | -54.8 | -16.6 | -81.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -53.7 | -55 | 120.8 |
| P/S | 3.6 | 19.9 | 9.7 |
| P/B | 3 | 12.7 | 738.2 |
| P/FCF | 111.3 | -53.5 | 111.3 |
| Market cap | $2.1 | $13.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 8.7 % | 0 % |
| Debt to Income | -199.8 % | -51.8 % | 0 % |
| Debt to Free cash flow | 414.3 % | -218 % | 0 % |
| Interest expense percentage | -0 % | -1.4 % | 18.1 % |
| Current ratio | 4.5 | 5.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -5.5 % | -44.7 % | 0 % |
| ROA | -4.2 % | -22.8 % | 0 % |
| CapEx to Revenue | 0.9 % | 12.2 % | 2.4 % |
| RaD to Revenue | 0 % | 38.9 % | 0 % |
| ROEM | 492,207.5 | 611222.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 69.1 % | 75.1 % | 89.7 % |
| Operating margin | -9.5 % | -48 % | 37.4 % |
| Net margin | -6.8 % | -48.4 % | 37.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 127.1 mil | 107.2 mil |
| Employee count | 1.3 tis | 0.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
